FIGURE 1.
Patient selection for the evaluation of treatment choices and the implementation of CDK4/6 inhibitors. CDK4/6, cyclin‐dependent kinase 4/6
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.